A study on association of hyperuricemia among patients of metabolic syndrome attending outpatient department of North Bengal Medical College and Hospital

Received: June 02, 2020; Accepted: June 30, 2020 ABSTRACTS Background: Metabolic syndrome (MS) refers to a group of modifiable risk factors consisting of insulin resistance, glucose intolerance, increased triglyceride and decreased high-density lipoprotein (HDL) cholesterol levels, and arterial hype...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:National journal of physiology, pharmacy and pharmacology pharmacy and pharmacology, 2020, Vol.10 (10), p.1-877
Hauptverfasser: Karmakar, Sukanta, Sarkar, Krishna, Ray, Achinta, Nath, Indrajit, Kumar, Anil, Arora, Neetu
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Received: June 02, 2020; Accepted: June 30, 2020 ABSTRACTS Background: Metabolic syndrome (MS) refers to a group of modifiable risk factors consisting of insulin resistance, glucose intolerance, increased triglyceride and decreased high-density lipoprotein (HDL) cholesterol levels, and arterial hypertension, occurring in some individuals and associated with an increased risk of developing cardiovascular disease and type 2 diabetes mellitus. Materials and Methods: Height, weight, blood pressure, waist circumference, body mass index (BMI), blood uric acid levels, fasting blood sugar levels, serum triglyceride, and serum HDL cholesterol measured among a group of298 subjects (198 cases and 100 controls) attending outpatient department ofNorth Bengal Medical College and Hospital. Study Variables This study was height, weight, blood pressure, waist circumference, body mass index (BMI), blood uric acid levels, fasting blood sugar levels, serum triglyceride, and serum HDL cholesterol. [...]this signifies that the wide variation in the values of the above parameters affects both sexes of MS patients equally.
ISSN:2320-4672
2231-3206
DOI:10.5455/njppp.2020.10.06163202030062020